Striving to provide balanced, scientific content related to care of patients with GU malignancies
Uromigos Live 2024: Peri-Operative Therapy in Bladder Cancer
Uromigos Live 2024: Will New Antibody Drug Conjugates Cure Bladder Cancer?
Uromigos Live 2024: T Cell Directed Therapy in Prostate Cancer
Uromigos Live 2024: Radioligands in Prostate Cancer
Uromigos Live 2024: Front-Line Therapy in RCC
Uromigos Live 2024: RCC IO Rechallenge
Topline x Uromigos
KIM-1 is a soluble protein with prognostic and predictive potential in resected RCC. Data from IMmotion 010 is discussed